Avanos Medical, Inc. Common Stock (AVNS)

The medical technology landscape witnessed a seismic shift on Tuesday as Avanos Medical (NYSE: AVNS) announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an all-cash transaction valued at approximately $1.27 billion. The deal marks a significant turning point

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

Let's have a look at the gap up and gap down stocks in today's session.

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

Avanos Medical (AVNS) Q3 2025 Earnings Transcript

Kimberly-Clark will pay $40.4 million to settle a criminal charge after selling mislabeled surgical gowns.

Avanos Medical (AVNS) beats Q2 2025 earnings with $175M revenue and $0.17 EPS, exceeding estimates. Shares surge 11.56% pre-market. New CFO appointed, outlook remains strong.

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

AVNS stock results show that Avanos Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.